Disease/Infection News

RSS

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

A recent study published in the journal Cellular & Molecular Immunology shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well, with important implications for our public health response.

1 Nov 2021

Study shows COVID vaccination highly protective against death, especially for older age groups

Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.

1 Nov 2021

Large U.S. study finds majority of mRNA COVID-19 side effects are mild and temporary

A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.

1 Nov 2021

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

31 Oct 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

Exercises using virtual reality to relieve COVID breathlessness

A recent study evaluates an immersive virtual reality-based digital intervention to alleviate refractory breathlessness in patients recovering from COVID-19.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Largest real-world study evaluates the effectiveness of third "booster" dose of COVID-19 vaccine

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2.

30 Oct 2021

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

University of Utah Health scientists are on the leading edge of a pair of large studies investigating the long-term effects of COVID-19.

30 Oct 2021

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Since March 2020, parents, educators, and politicians have debated whether to send children to school in person during the COVID-19 pandemic.

30 Oct 2021

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

New research addresses the misconception that children are less susceptible to infection with the new coronavirus.

30 Oct 2021

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

University of Utah Health scientists are leading an effort to determine if salivary glands infected with the virus that causes COVID-19 could diminish a person’s long-term immunity to the disease after being immunized or after recovering from the illness.

30 Oct 2021

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

When the delta variant of the coronavirus hit the Sierra Conservation Center — a low- to medium-security prison for men in California — residents who had received the Moderna vaccine were well protected against symptomatic infection, according to Stanford-led research.

30 Oct 2021

CDC announces $26 million to develop next-generation infectious disease forecasting and analytics

The Centers for Disease Control and Prevention (CDC) today announced $26 Million in funding to develop next-generation infectious disease forecasting and analytics.

30 Oct 2021

CDC: Cause of melioidosis outbreak confirmed

The Centers for Disease Control and Prevention today confirmed that bacteria in a Better Homes & Gardens aromatherapy spray in a Georgia melioidosis patient's home genetically matches the bacterial strains in the patient, and three other patients in Kansas, Minnesota, and Texas infected since March.

30 Oct 2021

Needle-free COVID-19 vaccine could soon be possible

A needle-free COVID-19 vaccination could be possible, with University of Queensland scientists successfully protecting mice from the virus by administering a US-developed vaccine candidate with a 'patch'.

30 Oct 2021

Disease/Infection News

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Study shows COVID vaccination highly protective against death, especially for older age groups

Large U.S. study finds majority of mRNA COVID-19 side effects are mild and temporary

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

New Canadian serology solution for SARS-CoV-2 infections and vaccination

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

Exercises using virtual reality to relieve COVID breathlessness

The ability of natural flavonoids to inhibit SARS-CoV-2

Largest real-world study evaluates the effectiveness of third "booster" dose of COVID-19 vaccine

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

CDC announces $26 million to develop next-generation infectious disease forecasting and analytics

CDC: Cause of melioidosis outbreak confirmed

Needle-free COVID-19 vaccine could soon be possible

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News